A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 ; volume:13 ; number:1 ; day:23 ; month:8 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (23.8.2023), 1-11, 12.2023

Creator: Iwahori, Kota
Nii, Takuro
Yamaguchi, Norihiko
Kawasaki, Takahiro
Okamura, Satomi
Hashimoto, Kazuki
Matsuki, Takanori
Tsujino, Kazuyuki
Miki, Keisuke
Osa, Akio
Goya, Sho
Abe, Kinya
Mori, Masahide
Takeda, Yoshito
Yamada, Tomomi
Kida, Hiroshi
Kumanogoh, Atsushi

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-41051-2

URN: urn:nbn:de:101:1-2024020112413199536487

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Iwahori, Kota
Nii, Takuro
Yamaguchi, Norihiko
Kawasaki, Takahiro
Okamura, Satomi
Hashimoto, Kazuki
Matsuki, Takanori
Tsujino, Kazuyuki
Miki, Keisuke
Osa, Akio
Goya, Sho
Abe, Kinya
Mori, Masahide
Takeda, Yoshito
Yamada, Tomomi
Kida, Hiroshi
Kumanogoh, Atsushi
SpringerLink (Online service)

Other Objects (12)

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Acupuncture for adolescents with mild-to-moderate myopia: study protocol for a randomized controlled trial

A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique

Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis

Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial

Related objects

Reset password